Bederocin
Alternative Names: methionyl tRNA synthetase inhibitor; REP 8839Latest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer Cardiovascular Systems
- Class Antibacterials; Quinolines; Small molecules; Thiophenes
- Mechanism of Action Methionine tRNA ligase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Skin and soft tissue infections; Staphylococcal infections
Most Recent Events
- 02 Oct 2007 Data presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapeutics added to the Bacterial Infections antimicrobial activity section
- 26 Jun 2007 Clinical data added to the adverse events section
- 30 Oct 2006 Phase-I clinical trials in Staphylococcal infections in USA (Topical)